ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ORPH Open Orphan Plc

10.00
0.00 (0.00%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Open Orphan Plc LSE:ORPH London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.00 9.50 10.50 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Open Orphan Share Discussion Threads

Showing 12401 to 12422 of 30350 messages
Chat Pages: Latest  506  505  504  503  502  501  500  499  498  497  496  495  Older
DateSubjectAuthorDiscuss
30/1/2021
21:13
If this is correct surely its massive 🤷‍a94;️
A 10 minute resulted test 98% + accurate & cheap as chips

bobdobalina
30/1/2021
21:12
Saliva not nasal swab, that's a bonus.
chopsy
30/1/2021
20:27
#ORPH #BTNX
IMHO Game-Changing news yet to be RNSed.

These test kits change the antigen testing landscape.

These kits are CE marked with very high accuracy results in rapid time.

elrico
30/1/2021
19:14
Interesting bit of bonus news if proven true.
mark10101
30/1/2021
18:56
Woah - why don't we have an RNS on this??!
king suarez
30/1/2021
18:43
£10 per test, 25 tests in a kit. Very affordable.
gregb
30/1/2021
18:17
Wow
Surely that’s big news?

judijudi
30/1/2021
17:00
Great research here. Not mine. With thanks to Eskers.


Interesting post by Maurice Treacy (Orph director) on LinkedIn today....

m5
30/1/2021
09:49
#ORPH Challenge studies
elrico
30/1/2021
08:09
“Are they all equally effective?

It is hard to compare one company's results with another as their trials will have been conducted in slightly different ways and at points in the pandemic.
However, all the main vaccines seem to have a large impact on your chances of needing hospital treatment or dying from Covid.

However, one of the most important questions - do they stop you spreading the virus - remains unknown.

Understanding which method produces the best results will be explored in challenge trials where people are deliberately infected with the virus.
What drugs can help treat coronavirus?”

mark10101
29/1/2021
22:39
It’s underwritten. They would not do this without “a plan”
What it is ;?who knows but it’s significant given the size

jimzi
29/1/2021
20:44
Biondvax raising money with what looks like a boilerplate "No current commitments or agreements" statement regarding acquisitions. I suppose that might not rule out them being in advanced negotiations to allow orph to reverse (non-core assets) in, and conceivably some of the cash could be to allow them to pay ORPH a cash sweetener to secure a deal. The second statement below would perhaps cover a potential deal with either ORPH or ConserV.

"The Company may also use a portion of any net proceeds to in-license, invest in or acquire businesses, assets or technologies that BiondVax believes are complementary to its business focus, although BiondVax has no current commitments or agreements in those regards."

"The company is now pursuing opportunities in the infectious disease space, including exploring several alternatives for development of a pipeline of assets."

1gw
29/1/2021
20:19
Melvin Capital lost 5 billion
malcolmmm
29/1/2021
17:23
What I am looking for in CFs interview next week is a clue to which big RNS is coming first, can he keep himself from not giving us a clue? Dont think so. The one I want is the wearables which I believe is going to transform the company into a data lead one which is what he said we would be this year, imagine challenge studies being secondary to data? Think about that for a minute and how much money he is thinking about there.
I try not to post these days but its after hours Friday no harm in a bit of speculation :0)

pogue
29/1/2021
16:19
Well I can definitely say I have had better weeks on the markets. I do hope that CF can put a bit of spark under the sp, because we sure could do with it. Good weekend all.
m5
29/1/2021
16:14
Yeah they're all buys today ... that's why the share price has fallen 4%Get real, face reality and accept that these shares are being dumped in blocks
12toes
29/1/2021
16:07
As they are all delayed quite a few are actually buys. Main trades are delayed from the day before, posted after close, however even those have shown buys and sells.
troutisout
29/1/2021
15:53
The big seller is dumping into any buys, I've noted 30000, 50000, 60000 blocks over the last few weeks, always in 000s
12toes
29/1/2021
15:52
Unfortunately it won't do anything for the share price until the big seller is out
12toes
29/1/2021
15:17
AJ Bell are hosting Orph webcast next Wednesday. If CF is in normal form then should inspire the share price
nashwan123
29/1/2021
13:26
Just had a look : Spreadex only taking sells atm. Its existing book shows as 100% long.
extrader
29/1/2021
13:16
1gw29 Jan '21 - 12:19 - 11122 of 11123

I would agree with that. I am sure a lot of people will be listening to CF next week. Certainly news is due on various fronts and looking back to the last presentation and guidance given by CF it does not want to be stretched too much longer. Maybe we will get some news prior to his presentation. That would not surprise me whatsoever. I think February is going to be a big month for us.

m5
Chat Pages: Latest  506  505  504  503  502  501  500  499  498  497  496  495  Older

Your Recent History

Delayed Upgrade Clock